Cargando…
P2X7 receptor inhibition ameliorates ubiquitin–proteasome system dysfunction associated with Alzheimer’s disease
BACKGROUND: Over recent years, increasing evidence suggests a causal relationship between neurofibrillary tangles (NFTs) formation, the main histopathological hallmark of tauopathies, including Alzheimer’s disease (AD), and the ubiquitin–proteasome system (UPS) dysfunction detected in these patients...
Autores principales: | Bianchi, Carolina, Alvarez-Castelao, Beatriz, Sebastián-Serrano, Álvaro, Di Lauro, Caterina, Soria-Tobar, Lucia, Nicke, Annette, Engel, Tobias, Díaz-Hernández, Miguel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10245610/ https://www.ncbi.nlm.nih.gov/pubmed/37287063 http://dx.doi.org/10.1186/s13195-023-01258-x |
Ejemplares similares
-
TNAP and P2X7R: New Plasma Biomarkers for Alzheimer’s Disease
por: Aivar, Paloma, et al.
Publicado: (2023) -
The N-Terminal Region of Nurr1 (a.a 1–31) Is Essential for Its Efficient Degradation by the Ubiquitin Proteasome Pathway
por: Alvarez-Castelao, Beatriz, et al.
Publicado: (2013) -
The ubiquitin-proteasome system in Alzheimer's disease
por: Oddo, Salvatore
Publicado: (2008) -
Role of the ubiquitin proteasome system in Alzheimer's disease
por: Upadhya, Sudarshan C, et al.
Publicado: (2007) -
Partial inhibition of the ubiquitin–proteasome system ameliorates cardiac dysfunction following ischemia–reperfusion in the presence of high glucose
por: Adams, Buin, et al.
Publicado: (2015)